IMDZ - Immune Design Corp.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue2,1967,19513,2609,510
Cost of Revenue1,43543,75445,61533,861
Gross Profit761-36,559-32,355-24,351
Operating Expenses
Research Development42,41542,41542,41542,415
Selling General and Administrative15,39616,25315,95915,134
Non Recurring----
Others----
Total Operating Expenses59,24660,00761,57448,995
Operating Income or Loss-57,050-52,812-48,314-39,485
Income from Continuing Operations
Total Other Income/Expenses Net2,292950-5,21640
Earnings Before Interest and Taxes-57,050-52,812-48,314-39,485
Interest Expense----
Income Before Tax-54,758-51,862-53,530-39,445
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-54,758-51,862-53,530-39,445
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-54,758-51,862-53,530-39,445
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-54,758-51,862-53,530-39,445